Exploring the Serum Level of RE1 Silencing Transcription Factor in Alzheimer’s Disease
Objective The aim of this study was to evaluate the serum RE1 silencing transcription factor (REST) level in Alzheimer’s disease (AD), mild cognitive impairment (MCI), and elderly controls by using surface plasmon resonance (SPR) technology. Materials and Methods In this case–control stud...
Guardado en:
Autores principales: | Shashank Shekhar, Manjari Tripathi, A. B. Dey, Sharmistha Dey |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3e0edb7d0a09496186c9c801ccf532ad |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
COVID-19 Pandemic: Perspective on Medical Professionalism
por: Harnoor Kaur Sra, et al.
Publicado: (2021) -
Leprosy Masquerading as Tinea Faciale
por: Manju Daroach, et al.
Publicado: (2021) -
Deterioro cognitivo leve y enfermedad de Alzheimer inicial en adultos mayores
por: Donoso,Archibaldo, et al.
Publicado: (2001) -
Papillary Carcinoma: A Rare Cause Of Cutaneous Lesion on Dorsum of Nose
por: Soumick Ranjan Sahoo, et al.
Publicado: (2021) -
Biomarkers in Alzheimer’s disease
por: Janeiro Manuel H., et al.
Publicado: (2020)